Health Canada inspection
Novartis Singapore Pharmaceutical Manufacturing PTE Ltd.: Health Canada inspection of Dec 8, 2023
Health Canada · GMP · rating C
Key facts
| Establishment | Novartis Singapore Pharmaceutical Manufacturing PTE Ltd. |
|---|---|
| City | Singapore |
| Country | Singapore |
| Program | GMP |
| Start date | Dec 8, 2023 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.